Balanced news tone
News Sentiment
AFT sentiment intelligence
AFT Pharmaceuticals Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
51
Balanced news tone
20 relevant articles
Price is moving more forcefully than the current news tone suggests.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-4.3% over one week, -5.3% over four weeks, trend active, and near fair-value range.
AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Earnings
78/100 classification
One-week reaction
-4.3%
Price reacting lower
Trend fit
Trend active
-5.3% over four weeks
Fair value
15.5%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
6
Neutral
11
Negative
3
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
AFT Pharmaceuticals' (NZSE:AFT) Profits Appear To Have Quality Issues
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Solid Earnings May Not Tell The Whole Story For AFT Pharmaceuticals (NZSE:AFT)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Earnings Miss: AFT Pharmaceuticals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 25 May 2026 07:00
- Source
- Market source
simplywall.st
Direct company coverage
AFT Pharmaceuticals (NZSE:AFT) EPS Rebound Tests Premium P/E And Non Cash Earnings Concerns
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 23 May 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
AFT Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 23 May 2026 07:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Here's Why We Think AFT Pharmaceuticals (NZSE:AFT) Is Well Worth Watching
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- simplywall.st
RNZ
Direct company coverage
AFT Pharmaceuticals lifts its 2027 revenue target to above $300 million
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 May 2026 07:00
- Source
- RNZ
smallcaps.com.au
Direct company coverage
AFT Pharmaceuticals Targets Minimum $300m Revenue After Record Earnings
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- smallcaps.com.au
marketscreener.com
Direct company coverage
AFT Pharmaceuticals targets FY27 revenue above NZ$300 mln
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 20 May 2026 07:00
- Source
- marketscreener.com
The Globe and Mail
Direct company coverage
AFT Pharmaceuticals appoints new CFO to support global growth
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- The Globe and Mail
Moomoo
Direct company coverage
New Zealand Shares Fall; AFT Pharmaceuticals Appoints CFO
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 17 May 2026 07:00
- Source
- Moomoo
AD HOC NEWS
Direct company coverage
Hikma Pharmaceuticals PLC stock (GB00B128J450): Dividend hike and $250M buyback
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 11 May 2026 07:00
- Source
- AD HOC NEWS
Market source
Direct company coverage
Here's Why AFT Pharmaceuticals (NZSE:AFT) Has Caught The Eye Of Investors
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- Market source
Market source
Direct company coverage
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jan 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Is AFT Pharmaceuticals (NZSE:AFT) Using Too Much Debt?
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 21 Nov 2025 08:00
- Source
- simplywall.st
simplywall.st
Direct company coverage
Earnings Tell The Story For AFT Pharmaceuticals Limited (NZSE:AFT) As Its Stock Soars 27%
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 17 Oct 2025 07:00
- Source
- simplywall.st
Market source
Direct company coverage
69% of AFT Pharmaceuticals Limited (NZSE:AFT) is owned by insiders, and they've been buying recently
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Aug 2025 07:00
- Source
- Market source
RNZ
Direct company coverage
AFT Pharmaceuticals profit drops despite sales up 10 percent
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 22 May 2025 07:00
- Source
- RNZ
Fat Tail Daily
Direct company coverage
AFT Pharmaceuticals [ASX:AFP] Admits to Profit Slide Yet Declares Maiden Dividend
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 22 May 2023 07:00
- Source
- Fat Tail Daily
StockInvest.us
Direct company coverage
Aft Pharmaceuticals Stock Price Forecast. Should You Buy AFT.NZ?
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 12 Dec 2020 04:22
- Source
- StockInvest.us